This event goes beyond innovation and partnerships — it’s a platform that acknowledges the contribution of the individuals who transform ideas into impact. Every achievement is driven by commitment, resilience, and vision of people working to advance healthcare.

This year, we are proud to highlight the women representing Venus Pharma GmbH. Their journeys reflect strength, professionalism, and the evolving role of women in shaping the global healthcare industry.

As CPhI 2025 unfolds, we take pride in highlighting the roles of these exceptional women of Venus. They are the professionals whose expertise and determination continue to drive progress across the world.

Why Women at CPhI Matter

CPhI is more than a pharmaceutical summit — it’s a platform where the future of medicine takes shape through shared ideas, innovation, and collaboration. The presence of women in this space represents more than visibility; it signifies progress toward greater equality and leadership across the global pharma landscape.

Across the industry, women now make up nearly half of the total workforce (International Labour Organization, 2023). However, only about one in four leadership positions are held by women (Deloitte Global Life Sciences Outlook, 2024). In research and development, this representation is even lower — a reminder that while meaningful strides have been made, there is still work ahead.

Events like CPhI play a vital role in accelerating this change. They provide women with opportunities to lead discussions, share insights, and forge partnerships that advance healthcare. Whether driving business development, expanding markets, or navigating regulatory frameworks, women are shaping strategies that strengthen their organizations and inspire the next generation of professionals (McKinsey Women in Pharma Report, 2023).

At Venus Pharma GmbH, we believe visibility opens doors for opportunity. That’s why we are proud of the women whose industry understanding, dedication, and leadership embody the spirit of progress at CPhI 2025.

Driving Our Mission: The Women at CPhI 2025

Every woman representing the Venus Pharma Germany teams brings a unique blend of proficiency, resilience, and leadership. Their influence goes far beyond their roles, shaping our values, culture, and the impact we create.

At CPhI 2025, these experts are not only showcasing our capabilities on a global stage but also demonstrating how women’s voices are actively shaping the future of healthcare. Through their contributions, they inspire innovation, foster collaboration, and set a standard for leadership that empowers others to follow.

Aditi K Chaudhary

Innovating International Business with Purpose and Vision

‍Aditi K Chaudhary As President of International Business, Ms. Aditi K Chaudhary brings together technical knowledge and strategic insight to the team. Since joining in 2021, she has infused the division with fresh energy, supported by a strong academic background—a Bachelor’s in Engineering from Vellore Institute of Technology and a Master’s in Business Analytics and Machine Learning from Columbia University, one of the world’s leading Ivy League institutions.

Her approach combines data-driven decision-making with a deep cultural understanding gained through extensive global travel. This enables her to engage effectively with partners and adapt seamlessly to diverse markets. Aditi represents the next generation of leadership, driving innovation, growth, and strengthening international collaborations.

Monica Atri

Connecting Markets, Empowering Partnerships

With over twenty years of experience in international business development, Ms. Monica Atri has played a pivotal role in our global expansion. She connects with partners across cultures, transforming these relationships into long-lasting collaborations.

Her leadership extends beyond business strategy—it focuses on guiding teams, uniting people, and opening new avenues for opportunity. She continues her mission of bringing quality medicines to patients around the world.

Andrijana Pekovic

Transforming Connections into Meaningful Partnerships

As Assistant Manager, International Business at Venus Pharma GmbH, Ms. Andrijana Pekovic brings focus, dedication, and energy to the team. Her efforts in establishing international connections highlight the critical role strong networks play in today’s pharmaceutical landscape.

She exemplifies the impact of collaboration—transforming connections into meaningful partnerships that enhance access to healthcare globally.

Sakshi Soi

Delivering Results with Precision and Innovation

Ms. Sakshi Soi brings over 15 years of experience in international business and has established herself as a trusted partner in managing clients across Europe and the Middle East. She is recognized for her ability to balance precision with adaptability, consistently meeting the quality standards while identifying solutions that drive growth.

Her dependability makes her an integral part of the Venus ****global business team. Sakshi embodies both trust and innovation — values that underpin our partnerships worldwide.

Olha Mykhalchuk

Strengthening Global Ties for Better Healthcare in the CIS Region

As Assistant Manager at Venus Pharma GmbH, Ms. Olha Mykhalchuk leads International Marketing and Business Development for the CIS region. She brings insight, energy, and strategic focus to her role, viewing CPhI Frankfurt as more than a networking event — it is an opportunity to strengthen partnerships that advance global health.

She believes that meaningful collaborations can create a healthier world, reflecting the core CPhI value of working together for the greater good.

Innovation Powered by Women

The presence of women at CPhI represents more than individual accomplishments. It highlights how diverse perspectives and leadership are driving tangible progress in the pharmaceutical industry, from innovations to patient care solutions.

At Venus, we are proud to showcase these professionals as ambassadors of our values on a global stage. Their contributions — leading strategic discussions, fostering international partnerships, and shaping solutions — extend the influence of our work far beyond the borders.

As CPhI 2025 approaches, they exemplify how inclusive leadership accelerates innovation and ensures that critical healthcare solutions reach communities that need them most.

Together, we are committed to building a future where innovation, diversity, and empathy form the foundation of global pharma, creating lasting impact for patients and professionals alike.

‍